Trial of Specific Antigen-Mediated Leukocyte Adherence Inhibition Test in Patients with Chronic Active Hepatitis and Hepatitis B Carrier

In the pathogenesis of chronic active hepatitis, the importance of cell mediated immunity (CMI) has been emphasized. Leukocyte adherence inhibition (LAI) assay, which is one of the methods for analysis of the reaction of CMI, has been used to analysie the CMI of cancer patients.

Bibliographic Details
Main Authors: Oh, Yong II, Song, Seock Hyun, Kim, Weon Ho, Cho, Kwang Ho, An, Joong Ki, Ahn, Deuk Soo
Format: Online
Language:English
Published: Korean Association of Internal Medicine 1986
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536717/